Investors

Article – Pulsed Electromagnetism: The Healing Revolution You Can’t Use http://www.nurse.org/wa/arnpcare/0601care.pdf

Powerful New Study Details the FDA Role in Med-Tech Innovation
http://medicaldevices.org/node/846

MedTech’s Response to FDA’s 510k Task Force
http://bielcorp.com/wp-content/uploads/2010/11/MedTech.pdf

BioElectronics Corporation (OTCPK: BIEL) is the maker of inexpensive, drug–free, anti-inflammatory medical devices and patches. The Company’s wafer thin patches contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch™, Allay Menstrual Pain therapy, RecoveryRx™, and HealFast Therapy for cats, dogs and horses.  The company is headquartered in Frederick, MD.

Get The Most Current Price Information On BioElectronics Corp. BIEL Including Quote Summary, Trade Data, Price History, 52 Week High, Low
http://www.otcmarkets.com/stock/biel/quote

The dermal patch delivery system creates a multitude of new product opportunities for chronic and acute inflammatory conditions. The market potential is estimated at $10 billion or 400 million incidents worldwide. The distinctive value proposition of ActiPatch is the delivery of drug-free therapy that reduces pain and inflammation and accelerates healing by 30% to 50% when compared with the present standard methods of patient care. The current major applications are:

Medical Surgeries

• Chronic Wounds
• Oral Surgeries
• Sprains and Strains
• Lower Back Pain
• Chronic Repetitive Stress Injuries, Heel Pain, Carpal Tunnel, Bursitis, etc.

Below is a list of the Company’s accomplishments to date.

• United States Food and Drug Administration market clearance
• Canadian market approval for relief of pain in muscosketal complaints and menstrual relief in both medical and over-the-counter markets
• CE Mark (European Common Market) Certification for the medical and retail over-the-counter markets
• ISO Certification
• Chosen as “One of 9 Medical Breakthroughs That May Change Your Life” by MedicalHeadway.com
• Sold over 200,000 units around the world in 40+ countries
• A solid intellectual property portfolio covering both the product design and the pulse signature.
• A 3-year pipeline of new products for treatment of sports injuries, bone fractures, chronic injuries, chronic wounds, skin conditions, arthritis and post-operative care.
• Awarded the 2009 Wall Street Journal Technology Innovation medical devices runner up award

If you have any questions, please call 1-866-757-2284 or e-mail IR@bielcorp.com.  Thank you for your support!